General ENT News

ENT

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Day JH et al. - L/M reduced nasal congestion as indicated by significant improvements in both the nasal congestion score and the PNIF measurements within 1 hour and 15 minutes postdose. The incidence of treatment-emergent adverse events was similar between groups. The onset of action after treatment with L/M was 1 hour and 15 minutes for TSS, as well as nasal congestion. L/M was well tolerated.


   

Today in Allergy...keeping you current

Oral Allergy Syndrome
Allergology International, 10/30/09

Montelukast in the treatment of asthma and beyond
Expert Review of Clinical Immunology, 11/23/09

Clinical Studies of Combination Montelukast and Loratadine in Patients with Seasonal Allergic Rhinitis
Journal of Asthma, 11/11/09

Today in Nose...keeping you current

Role of adenoids and adenoiditis in children with allergy and otitis media
Current Allergy and Asthma Reports, 10/22/09

Montelukast in the treatment of asthma and beyond
Expert Review of Clinical Immunology, 11/23/09

Saline Nasal Irrigation for Upper Respiratory Conditions
American Family Physician, 11/12/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address